Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Control of Smad7 stability by competition between acetylation and ubiquitination.

Grönroos E, Hellman U, Heldin CH, Ericsson J.

Mol Cell. 2002 Sep;10(3):483-93.

2.

[TGFbeta, activin and SMAD signalling in thyroid cancer].

Kimura ET, Matsuo SE, Ricarte-Filho JC.

Arq Bras Endocrinol Metabol. 2007 Jul;51(5):683-9. Review. Portuguese.

3.

Regulation of TGF-beta family signaling by E3 ubiquitin ligases.

Inoue Y, Imamura T.

Cancer Sci. 2008 Nov;99(11):2107-12. doi: 10.1111/j.1349-7006.2008.00925.x. Epub 2008 Sep 18. Review.

4.

Smad regulation in TGF-beta signal transduction.

Moustakas A, Souchelnytskyi S, Heldin CH.

J Cell Sci. 2001 Dec;114(Pt 24):4359-69. Review.

5.

Ubiquitin modifications.

Swatek KN, Komander D.

Cell Res. 2016 Apr;26(4):399-422. doi: 10.1038/cr.2016.39. Epub 2016 Mar 25. Review.

6.

Regulation of the transforming growth factor β pathway by reversible ubiquitylation.

Al-Salihi MA, Herhaus L, Sapkota GP.

Open Biol. 2012 May;2(5):120082. doi: 10.1098/rsob.120082. Review.

7.

Lysine-targeting specificity in ubiquitin and ubiquitin-like modification pathways.

Mattiroli F, Sixma TK.

Nat Struct Mol Biol. 2014 Apr;21(4):308-16. doi: 10.1038/nsmb.2792. Review.

PMID:
24699079

Supplemental Content

Support Center